COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 2043: Articles 20421-20430  | Next

A holistic approach for suppression of COVID-19 spread in workplaces and universities
Poole, S. F., Gronsbell, J., Winter, D., Nickels, S., Levy, R., Fu, B., Burq, M., Saeb, S., Edwards, M. D., Behr, M. K., Kumaresan, V., Macalalad, A. R., Shah, S., Prevost, M., Snoad, N., Brenner, M. P., Myers, L. J., Varghese, P., Califf, R. M., Washington, V., Lee, V. S., Fromer, M.
10.1101/2020.12.03.20243626 — Posted: 2020-12-04
Household factors and the risk of severe COVID-like illness early in the US pandemic
Nash, D., Qasmieh, S., Robertson, M., Rane, M., Zimba, R., Kulkarni, S. G., Berry, A., You, W., Mirzayi, C., Westmoreland, D., Parcesepe, A., Waldron, L., Kochhar, S., Maroko, A. R., Grov, C., CHASING COVID Cohort Study Team
10.1101/2020.12.03.20243683 — Posted: 2020-12-04
Novel Approach for Monte Carlo Simulation of the new COVID-19 Spread Dynamics
Maltezos, S., Georgakopoulou, A.
10.1101/2020.12.03.20243220 — Posted: 2020-12-04
A first-in-human evaluation of the safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19 in healthy adults; a phase 1, randomised, double-blind, placebo-controlled trial
Richmond, P., Hetchual, L., Dong, M., Ma, B., Hu, B., Smolenov, I., Li, P., Liang, P., Han, H. H., Liang, J., Clemens, R.
10.1101/2020.12.03.20243709 — Posted: 2020-12-04
Risk factors for severe illness and death in COVID-19: a systematic review and meta-analysis
Degarege, A., Naveed, Z., Kabayundo, J., Brett-Major, D.
10.1101/2020.12.03.20243659 — Posted: 2020-12-04
Galectin antagonist use in mild cases of SARS-CoV-2 cases; pilot feasibility randomised, open label, controlled trial
SIGAMANI, A., SIGAMANI, A., KADAMBI, M., RUTHRA, M., SHIVAPRASAD, S., CHUGANI, A., CHEN-WALDEN, H., ALUMPARAMBILL, T., PLATT, D.
10.1101/2020.12.03.20238840 — Posted: 2020-12-04
Detailed disease progression of 213 patients hospitalized with Covid-19 in the Czech Republic: An exploratory analysis
Modrak, M., Burkner, P.-C., Sieger, T., Slisz, T., Vasakova, M., Meseznikov, G., Casas-Mendez, L. F., Vajter, J., Taborsky, J., Kubricht, V., Suk, D., Horejsek, J., Jedlicka, M., Mifkova, A., Jaros, A., Kubiska, M., Vachalova, J., Sin, R., Veverkova, M., Pospisil, Z., Vohryzkova, J., Pokrievkova, R., Hrusak, K., Christozova, K., Leos-Barajas, V., Fiser, K., Hyanek, T.
10.1101/2020.12.03.20239863 — Posted: 2020-12-04
Tolerability and Pharmacokinetic Evaluation of Inhaled Dry Powder Hydroxychloroquine in Healthy Volunteers
de Reus, Y., Hagedoorn, P., Sturkenboom, M., Grasmeijer, F., Bolhuis, M., Sibum, I., Kerstjens, H., Frijlink, E., Akkerman, O.
10.1101/2020.12.03.20243162 — Posted: 2020-12-04
Factors associated with decision making on COVID-19 vaccine acceptance among college students in South Carolina
Tam, C. C., Qiao, S., Li, X.
10.1101/2020.12.03.20243543 — Posted: 2020-12-04
The application of Hybrid deep learning Approach to evaluate chest ray images for the diagnosis of pneumonia in children
Abbasa, M. A., Bukhari, S. U. K., Bokhari, S. K. A., niazi, m.
10.1101/2020.12.03.20243550 — Posted: 2020-12-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).